Skip to main content

Main menu

  • About
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Strategic Plan
    • News and Stories
    • Careers
  • Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health
      • Healthy Aging and Mobility
      • Heart Health
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
      • Other Research Focus Areas
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Dilawri Cardiovascular Institute
      • Djavad Mowafaghian Centre for Brain Health
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
    • Research Cores
      • Clinical Trials Platform
      • VCH-VCHRI AI Hub
      • Indigenous Health Research Unit
    • Researcher Directory
    • Events and Workshops
    • Participate in Research
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
    • Research Development
      • Awards and Funding
      • Research Facilitation
      • Grant Management
      • Learning and Development
    • Contracts and Compliance
      • Contract Facilitation at VCHRI
      • Operational Approval
      • Research Privacy
      • Clinical Trials Administration
    • Research Support
      • Communications and Media Relations
      • Financial Policies and Procedures
      • VCH-VCHRI AI Hub
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Clinical Trials
    • Clinical Trials Platform
      • Phase 1 Clinical Trials Research Unit
      • Hematology Research Unit
      • Clinical Research Unit
    • Find a Study
    • Researcher Directory
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Research
  3. Participate in Research
  4. Discovering newfound freedom from an enlarged prostate

Discovering newfound freedom from an enlarged prostate

Participate in Research Sep 6, 2019 4 minutes

"I say yes to participating because I wanted to see an improvement in my quality of life and help other guys with prostate enlargement.”

– Lloyd LeBlanc, Sechelt

It was a reality Lloyd LeBlanc had learned to live with. At night, he would wake up to relieve himself every two hours. During the day, he would have to run to a washroom or wait with the discomfort of not being able to urinate at all. LeBlanc’s enlarged prostate had, in short, taken over his life.

“Traveling and changes in routine were often issues,” says the 74-year-old retired accountant. “At work, we would be in meetings sometimes and I would have to go to the washroom before the break.”

Leblanc takes a break with his son’s dog.

LeBlanc was in his 50s when he first noticed symptoms of prostate enlargement. He had difficulty urinating, and when he did it was often accompanied by a burning sensation and an inability to completely empty his bladder.

As his condition progressed, LeBlanc increasingly had the need but not the ability to go, and would have to sit down and wait until he could. At other times, he would urgently need to find a washroom or, in desperation, a bush. 

“You get to know where to find a bathroom wherever you’re going. If you go to a store, you have to find a bathroom.” 

On top of the inconvenience, there was a growing risk that an ongoing backup of urine in his bladder could damage LeBlanc’s kidneys. 

His longtime urologist—Vancouver Coastal Health Research Institute (VCHRI) scientist Dr. Larry Goldenberg—asked LeBlanc if he was interested in participating in a clinical trial to treat his enlarged prostate. It was for a novel approach called the AQUABEAM Robotic System that combines multi-dimensional imaging, robotics and heat-free waterjet ablation for targeted, personalized and immediate removal of prostate tissue. LeBlanc unconditionally agreed. 

Finding the right approach to treat a common condition

Almost all men will experience some form of prostate enlargement by age 60, according to the Canadian Cancer Society. 

The condition, technically called benign prostatic hyperplasia (BPH), is usually part of the natural aging process. It is non-cancerous and only becomes problematic when it causes adverse symptoms, such as kidney, bladder and urinary tract problems. In severe cases, a man’s prostate may grow so large that it cuts off the flow of urine completely. 

In British Columbia, there were 4,360 prostatectomies performed for benign prostatic enlargement in 2014/2015.

Treatment for BPH ranges from lifestyle changes to medication and surgery. There are many surgical approaches—the most common of which is the transurethral resection of the prostate (TURP) procedure. All involve removing prostate tissue that is blocking the flow of urine. 

LeBlanc was among three men who participated in the Vancouver arm of a clinical trial and received the Aquablation therapy. The study was facilitated at the VCHRI Clinical Research Unit. A small telescope was inserted through their urethras and high-pressure water jets were used to remove enlarged prostate tissue while sparing nearby structures, such as the neck of the bladder and urinary sphincter. 

“As far as I’m concerned, it was a total success,” says LeBlanc.

“Now I don’t have to get up in the night at all to go to the bathroom. I can quickly empty my bladder and know that my bladder is completely empty.”

Dr. Ryan Paterson, a VCHRI researcher and vice-chair of Clinical Operations at the UBC Department of Urologic Sciences, says the clinical trial highlighted the importance of further integrating diagnostic and therapeutic ultrasound technology into their clinical practice.

“Greater access to and use of ultrasound technology means we could remove targeted tissue, lowering the risk of potential damage to the bladder, ejaculatory ducts and urinary sphincter,” states Paterson.  

With his newfound freedom from the symptoms of an enlarged prostate, LeBlanc has more time to go sailing and camping, and to work on projects for his wife’s interior design business—reupholstering couches, installing window blinds and doing some accounting too. He is also looking for a bathroom much less often.

“Now, when my wife and I go down to the beach after dinner with a bottle of wine to watch the sun go down, I don’t need to go to the bathroom after every glass,” LeBlanc says with a smile.
 

THIS IS ONE PATIENT’S STORY OF PARTICIPATING IN A CLINICAL TRIAL. YOUR EXPERIENCE MAY DIFFER. LEARN MORE ABOUT CLINICAL TRIALS BEFORE PARTICIPATING.

Researchers

Ryan Paterson
Larry Goldenberg

Related Articles

Researchers discover new form of hereditary prostate cancer

Newly discovered protein functions linked to metastatic prostate cancer

Precision care for treatment-resistant prostate cancer

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Instagram
  • Email

Related Research Centres/Programs

Vancouver Prostate Centre

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Stories

Ask an expert: How can I strike a healthier balance with my daily habits?

Sep 10, 2026 exercise, mobility
Type
Stories

Moving endometrial cancer prevention upstream

Sep 8, 2026 women, cancer, uterine
Type
Stories

Improving respiratory protection for wildland firefighters

Sep 3, 2026 lung, environment, safety
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • Instagram
  • Bluesky
  • YouTube

© 2026 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy